[PDF][PDF] The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin
Journal of Allergy and Clinical Immunology, 2022•Elsevier
2. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel
coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348
(20): 1953-66. 3. Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD,
Xie X, et al. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and
vaccine evaluation. Nat Commun. 2020; 11 (1): 4059.
coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348
(20): 1953-66. 3. Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD,
Xie X, et al. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and
vaccine evaluation. Nat Commun. 2020; 11 (1): 4059.
2. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348 (20): 1953-66. 3. Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD, Xie X, et al. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat Commun. 2020; 11 (1): 4059.
Elsevier
